recent
kit
base
multiplex
realtim
pcr
develop
simultan
detect
respiratori
virus
rv
compar
perform
advansur
rv
ace
cultur
determin
sensit
specif
composit
refer
standard
four
hundr
thirtyseven
respiratori
sampl
test
modifi
shell
vial
cultur
method
rv
ace
advansur
one
hundr
fourteen
sampl
sampl
posit
cultur
addit
posit
advansur
one
hundr
twelv
cultureposit
sampl
posit
advansur
except
sampl
adenoviru
respiratori
syncyti
viru
rsv
overal
sensit
cultur
advansur
respect
sensit
cultur
advansur
viru
test
follow
influenza
influenza
b
rsv
adenoviru
parainfluenza
viru
virus
cover
cultur
sensit
advansur
follow
rhinoviru
coronaviru
coronaviru
metapneumoviru
bocaviru
overal
specif
cultur
advansur
respect
coinfect
specimen
advansur
detect
specimen
coinfect
detect
specimen
coinfect
advansur
assay
demonstr
exquisit
perform
detect
rv
valuabl
tool
manag
rv
infect
human
viral
respiratori
infect
often
associ
signific
morbid
mortal
thompson
et
al
rapid
accur
diagnost
method
import
identifi
caus
pathogen
earli
stage
ill
initi
time
therapeut
intervent
limit
misus
drug
coira
et
al
zhang
et
al
diagnos
viral
respiratori
tract
infect
made
gener
nonmolecular
approach
direct
immunofluoresc
viral
cultur
although
method
effect
often
complementari
timeconsum
laborintens
often
lack
sensit
specif
bellaupujol
et
al
goosken
et
al
vallier
renaud
zhang
et
al
howev
variou
nucleic
acid
amplif
test
develop
employ
number
year
util
demonstr
larg
comparison
classic
diagnost
method
bibbi
et
al
gharabaghi
et
al
molecular
assay
offer
reduc
turnaround
time
consider
improv
sensit
choudhari
et
al
drew
et
al
vallier
renaud
progress
multiplex
simultan
detect
sever
differ
virus
singl
assay
maintain
excel
sensit
specif
choudhari
et
al
vallier
renaud
sever
studi
demonstr
advantag
multiplex
pcr
assay
xtag
rvp
rvp
fast
luminex
molecular
diagnost
toronto
canada
resplex
ii
qiagen
mississauga
canada
respiratori
panel
idaho
technolog
inc
salt
lake
citi
ut
usa
seeplex
rv
assay
seegen
seoul
korea
use
routin
detect
respiratori
viral
infect
bibbi
et
al
couturi
et
al
gharabaghi
et
al
kim
et
al
zhang
et
al
recent
respiratori
viru
rv
introduc
multiplex
realtim
revers
transcriptionpolymeras
chain
reaction
realtim
rtpcr
lg
life
scienc
seoul
korea
use
primer
set
simultan
detect
rv
tube
influenza
viru
type
b
parainfluenza
viru
piv
type
august
februari
nasopharyng
sampl
patient
consecut
collect
patient
acut
respiratori
infect
korea
univers
anam
hospit
seoul
korea
sampl
nasopharyng
aspir
flock
nasopharyng
swab
transport
ml
utm
copan
murrieta
ca
usa
freshli
use
viru
cultur
rv
assay
realtim
rtpcr
lg
life
scienc
studi
approv
research
ethic
board
korea
univers
anam
hospit
patient
frozenfreshcel
rmix
cell
diagnost
hybrid
athen
oh
usa
provid
cryovial
ship
dri
ice
accord
manufactur
instruct
thaw
cell
dilut
plant
medium
deliv
plate
cell
form
confluent
monolay
specimen
inocul
well
plate
plate
centrifug
first
well
use
screen
day
initi
screen
neg
second
well
examin
day
second
well
test
posit
day
third
well
use
confirm
result
fourth
well
use
viral
stock
viral
detect
rv
fluoresc
antibodi
pool
dfa
diagnost
hybrid
diagnost
hybrid
individu
monoclon
antibodi
use
nucleic
acid
extract
nasopharyng
sampl
use
marci
letoil
franc
per
manufactur
protocol
complementari
dna
cdna
synthesi
carri
first
strand
cdna
synthesi
kit
fermenta
burlington
canada
accord
manufactur
suggest
method
sampl
test
respiratori
viru
detect
kita
b
c
rv
ace
detect
kit
accord
manufactur
instruct
amplif
product
detect
use
capillari
electrophoresi
technolog
tape
system
ltd
loanhead
uk
nucleic
acid
rna
dna
extract
nasopharyng
sampl
use
tanbead
fulli
autom
magnet
bead
oper
platform
smart
tanbead
viral
auto
plate
taiwan
advanc
nanotech
inc
taoyuan
citi
taiwan
rv
realtim
kit
lg
life
scienc
use
detect
type
rna
virus
type
dna
virus
accord
manufactur
instruct
briefli
extract
nucleic
acid
ad
advansur
rv
realtim
pcr
reaction
tube
contain
primer
probe
mixtur
premix
oper
cdna
synthesi
realtim
pcr
revers
transcript
step
mixtur
incub
min
denatur
follow
cycl
pcr
addit
cycl
pcr
detect
fluoresc
signal
rv
realtim
rtpcr
perform
reversetranscript
reaction
extract
rna
multiplex
pcr
reaction
simultan
singl
tube
use
endogen
rnase
p
intern
control
give
inform
valid
rna
extract
procedur
prevent
misjudg
sampl
error
rtpcr
reaction
error
rna
extract
nasopharyng
sampl
addit
bacteriophag
intern
control
rv
detect
seegen
use
microlab
nimbu
ivd
hamilton
reno
nv
usa
starmag
viru
kit
seegen
autom
protocol
extract
rtpcr
pcr
setup
implement
use
nimbu
autom
liquid
handl
workstat
maxim
workflow
accuraci
intern
control
ad
specimen
work
exogen
control
check
whole
process
nucleic
acid
extract
rtpcr
cdna
synthesi
perform
cdna
synthesi
auto
mix
seegen
extract
rna
respiratori
viru
detect
kita
b
rv
detect
seegen
use
accord
manufactur
instruct
briefli
assay
conduct
final
volum
use
realtim
thermocycl
biorad
hercul
ca
usa
reaction
catcher
melt
temperatur
analysi
cmta
perform
cool
reaction
mixtur
hold
heat
hwang
singleplex
pcr
sequenc
primer
singleplex
pcr
singl
nest
pcr
format
ident
primer
previou
studi
arden
et
al
kapoor
et
al
lam
et
al
pcr
product
purifi
qia
quick
pcr
purif
kit
qiagen
hilden
germani
purifi
templat
sequenc
abi
prism
dna
sequenc
life
technolog
grand
island
ny
usa
perform
assay
determin
composit
refer
standard
gharabaghi
et
al
posit
result
method
cultur
consid
true
posit
neg
result
method
consid
true
neg
case
posit
result
pcr
assay
confirmatori
test
follow
posit
result
confirm
seegen
posit
result
neg
result
consid
fals
posit
posit
result
advansur
confirm
case
posit
result
advansur
neg
result
anoth
confirmatori
test
singleplex
pcr
sequenc
perform
main
outcom
studi
sensit
specif
cultur
rv
assay
cultur
detect
human
rhinoviru
hrv
mpv
coronaviru
bocaviru
exclud
hrv
mpv
coronaviru
bocaviru
result
sensit
analysi
cultur
specif
calcul
percentag
number
target
virusneg
specimen
assay
number
target
virusneg
specimen
composit
refer
standard
statist
analys
perform
use
spss
version
spss
chicago
il
usa
four
hundr
thirtyseven
respiratori
sampl
test
cultur
advansur
sampl
test
respiratori
viral
pathogen
detect
sampl
distribut
virus
singl
infect
coinfect
shown
tabl
fortyf
sampl
virus
coinfect
specimen
advansur
detect
specimen
coinfect
detect
specimen
coinfect
thirtyseven
sampl
virus
sampl
virus
studi
rsv
rhinovirus
virus
commonli
associ
multipl
agent
infect
follow
adenovirus
bocavirus
total
sampl
advansur
posit
sampl
cultur
posit
one
hundr
twelv
cultureposit
sampl
advansur
posit
except
sampl
adenoviru
rsv
tabl
tabl
sensit
target
assay
calcul
number
true
confirm
case
tabl
overal
sensit
cultur
advansur
respect
eight
target
virus
influenza
influenza
b
rsv
piv
coronaviru
coronaviru
bocaviru
mpv
demonstr
sensit
advansur
tabl
four
target
virus
influenza
rsv
piv
coronaviru
sensit
influenza
b
coronaviru
bocaviru
mpv
show
poor
sensit
howev
statist
signific
differ
pcr
assay
virus
except
mpv
cultur
show
fairli
good
sensit
influenza
piv
howev
cultur
show
lower
sensit
rsv
adenoviru
respect
overal
specif
cultur
advansur
respect
target
viru
specif
advansur
follow
influenza
influenza
b
rsv
adenoviru
piv
rhinoviru
coronaviru
coronaviru
mpv
bocaviru
thirti
sampl
posit
advansur
posit
discrep
sampl
addit
confirmatori
test
singleplex
pcr
sequenc
perform
taken
togeth
confirm
true
posit
composit
refer
standard
confirm
trueposit
virus
rhinovirus
mpv
bocavirus
rsv
influenza
b
virus
adenovirus
coronaviru
one
mpv
fals
posit
sixteen
sampl
posit
confirm
true
posit
rhinovirus
rsv
influenza
viru
adenovirus
two
rhinovirus
coronaviru
adenoviru
mpv
fals
posit
studi
evalu
perform
advansur
assay
assay
viral
cultur
agreement
advansur
assay
piv
coronaviru
pcr
assay
show
sensit
respect
sensit
advansur
slightli
higher
versu
statist
signific
differ
pcr
assay
detect
influenza
b
bocaviru
mpv
might
appar
differ
advansur
nevertheless
differ
statist
signific
like
due
low
number
target
virusposit
specimen
tabl
good
perform
advansur
found
multipl
virus
infect
specimen
coinfect
specimen
advansur
detect
specimen
coinfect
detect
specimen
coinfect
although
contradictori
conclus
clinic
impact
viral
coinfect
report
vallier
renaud
sever
studi
point
multipl
viru
infect
associ
sever
clinic
cours
bruijnesteijn
van
coppenraet
et
al
martin
et
al
simultan
control
coinfect
virus
becom
import
goal
medic
treatment
advansur
assay
would
provid
clinician
better
infecti
statu
patient
zhang
et
al
expect
advansur
show
sensit
superior
cultur
influenza
viral
cultur
show
good
sensit
similar
lower
sensit
rsv
adenoviru
studi
bruijnesteijn
van
coppenraet
et
al
sanghavi
et
al
among
influenza
b
posit
detect
cultur
advansur
none
detect
previou
studi
evalu
seeplex
detect
kit
seegen
rockvil
md
usa
viral
cultur
realtim
pcr
detect
influenza
bposit
specimen
respect
bruijnesteijn
van
coppenraet
et
al
studi
base
dual
prime
oligonucleotid
system
dpo
demonstr
less
clinic
sensit
detect
influenza
b
viral
cultur
realtim
pcr
show
greatest
analyt
clinic
sensit
similarli
studi
demonstr
dpo
technolog
less
sensit
influenza
b
viral
cultur
advansur
sensit
influenza
b
viru
viral
cultur
sensit
method
detect
rhinoviru
virus
mpv
coronaviru
lee
et
al
viral
cultur
limit
abil
detect
mani
serotyp
rhinoviru
greenberg
studi
advansur
detect
rhinovirus
cultureneg
sampl
although
mpv
caus
acut
respiratori
tract
infect
similar
caus
rsv
children
elderli
immunecompromis
patient
difficult
detect
mpv
cell
cultur
due
fastidi
growth
requir
mild
cytopath
feuillet
et
al
lee
et
al
studi
advansur
detect
mpv
cultureneg
sampl
spite
rel
low
sensit
cultur
posit
result
cultur
consid
true
posit
regard
tradit
gold
standard
shown
case
influenza
posit
cultur
neg
proflu
assay
genprob
prodess
inc
waukesha
wi
usa
mutat
target
site
could
rais
fals
neg
pcr
method
zheng
et
al
case
adenoviru
posit
cultur
neg
pcr
assay
studi
may
caus
mismatch
primer
andor
probe
bind
region
among
specimen
posit
advansur
confirm
true
posit
composit
refer
standard
specimen
high
cycl
threshold
valu
cutoff
advansur
indic
low
amount
target
viru
specimen
expect
realtim
pcr
system
advansur
sensit
base
capillari
electrophoresi
five
falseposit
case
comparison
case
advansur
might
caus
carri
contamin
process
rtpcr
andor
gel
electrophoresi
pcr
advansur
system
realtim
pcr
autom
nucleic
acid
extract
system
seem
abl
reduc
chanc
caliendo
kehl
kumar
olofsson
et
al
besid
advansur
realtim
pcr
technolog
advantag
decreas
turnaround
time
evalu
pcr
product
real
time
pcr
cycl
aid
semiquantit
method
distinguish
true
etiolog
agent
innoc
bystand
kehl
kumar
olofsson
et
al
introduct
simultan
molecular
diagnost
current
estim
preval
viral
coinfect
document
martin
et
al
vallier
renaud
similar
previou
studi
evalu
multiplex
realtim
pcr
virusesinfect
specimen
studi
total
respiratori
specimen
respect
gharabaghi
et
al
wang
et
al
rsv
rhinoviru
common
virus
detect
virus
howev
coinfect
rate
highest
bocaviru
coronaviru
bocaviru
alway
detect
virus
seven
coronaviru
codetect
virus
among
coronavirusposit
case
previou
studi
analyz
multipl
viral
respiratori
infect
among
childcar
attende
virus
frequent
coinfect
bocaviru
adenoviru
coronaviru
hrv
martin
et
al
similarli
studi
bocavirus
present
frequent
adenovirus
result
bocavirusinfect
sampl
coinfect
support
claim
develop
human
bocaviru
pathogen
may
requir
reciproc
interact
coinfect
virus
zhang
et
al
two
differ
extract
method
differ
input
volum
versu
smart
studi
use
accord
manufactur
instruct
differ
extract
method
could
partli
affect
differ
observ
howev
studi
need
evalu
accur
impact
differ
extract
system
perform
advansur
main
limit
studi
small
number
specimen
specif
viru
influenza
b
viru
coronaviru
coronaviru
bocaviru
mpv
requir
futur
studi
specimen
virus
nevertheless
note
advansur
show
improv
overal
sensit
also
compar
advansur
multiplex
convent
pcr
also
cultur
complement
shortcom
previou
studi
evalu
advansur
rheem
et
al
conclus
advansur
assay
demonstr
exquisit
perform
compar
well
cultur
method
addit
advansur
show
improv
sensit
detect
coinfect
maintain
excel
specif
advansur
promis
altern
molecular
multiplex
test
